Immune modulatory strategies: A playground with a swing and a seesaw

Expert Review of Anti-Infective Therapy

Volumn 10, Issue 3, 2012, Pages 249-251

  Hussell, Tracy ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

apoptosis; bacterial infections; cytokines; immunostimulation; macrolides; monocytes; sepsis

Indexed keywords

AUTOANTIGEN; CYTOKINE; TUMOR NECROSIS FACTOR;

ADAPTIVE IMMUNITY; ANTIGEN RECOGNITION; APOPTOSIS; CELL PHAGOCYTOSIS; CELLULAR IMMUNITY; CYTOKINE RESPONSE; EDITORIAL; HUMAN; IMMUNOMODULATION; IMMUNOPHENOTYPING; IMMUNOREACTIVITY; INFLAMMATION; INNATE IMMUNITY; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH2 CELL; TISSUE INJURY;

ADAPTIVE IMMUNITY; AGED; AGING; HUMANS; IMMUNITY, INNATE; IMMUNOMODULATION; INFANT, NEWBORN; INFECTION; INFLAMMATION;

EID: 84858232815     PISSN: 14787210     EISSN: 17448336     Source Type: Journal    
DOI: 10.1586/eri.12.12     Document Type: Editorial

References (14)

1. Labro MT. Immunomodulatory effects of antimicrobial agents. Part I: antibacterial and antiviral agents. Expert Rev. Anti Infect. Ther. 10(3), 319-340 (2012).
2. Labro MT. Immunomodulatory effects of antimicrobial agents. Part II: antiparasitic and antifungal agents. Expert Rev. Anti Infect. Ther. 10(3), 341-357 (2012).
3. Cieza RJ, Cao A, Cong Y, Torres AG. Immunomodulation for GI infections. Expert Rev. Anti Infect. Ther. 10(3), 391-400 (2012).
4. Cunha C, Carvalho A. Host genetics and invasive fungal diseases: towards improved diagnosis and therapy? Immunomodulation for GI infections. Expert Rev. Anti Infect. Ther. 10(3), 257-259 (2012).
5. Futata EA, Fusaro AE, de Brito CA, Sato MN. The neonatal immune system: immunomodulation of infections in early life. Immunomodulation for GI infections. Expert Rev. Anti Infect. Ther. 10(3), 289-298 (2012).
6. Goulding J, Snelgrove R, Saldana J et al. "Respiratory infections: do we ever recover?" Proc. Am. Thorac. Soc. 4, 618-625 (2007). (Pubitemid 350291624)
7. Boettler T, Neto EC, Kalil J, von Herrath M. Can an immune-regulatory vaccine prevent HIV infection? Expert Rev. Anti Infect. Ther. 10(3), 299-305 (2012).
8. Wisniewski T, Goni F. Could immunomodulation be used to prevent prion diseases? Expert Rev. Anti Infect. Ther. 10(3), 307-317 (2012).
9. Giamarellos-Bourboulis EJ, Raftogiannis M. The immune response to severe bacterial infections: consequences for therapy. Expert Rev. Anti Infect. Ther. 10(3), 369-380 (2012).
10. Bourinbaiar AS, Mezentseva MV, Butov DA et al. Immunotherapeutic approaches in tuberculosis therapy: a brief overview. Expert Rev. Anti Infect. Ther. 10(3), 381-389 (2012).
11. Mukhopadhyay D, Saha P, Chatterjee M. Targets for immunochemotherapy in Leishmaniasis. Expert Rev. Anti Infect. Ther. 10(3), 261-264 (2012).
12. Hassan T, McKiernan PJ, McElvaney NG, Cryan SA, Greene CM. Therapeutic modulation of microRNA for the treatment of pro-inflammatory lung diseases. Expert Rev. Anti Infect. Ther. 10(3), 359-368 (2012).
13. Moos V, Schneider T. The role of T cells in the pathogenesis of classical Whipple's disease. Expert Rev. Anti Infect. Ther. 10(3), 253-255 (2012).
14. Snelgrove RJ. Pulmonary innate lymphoid cells (ILCs) regulate repair and remodelling after acute lung injury. Expert Rev. Anti Infect. Ther. 10(3), 281-284 (2012).